- Peters, Marion;
- Price, H;
- Dunn, D;
- Pillay, D;
- Bani-Sadr, F;
- de, T;
- Jain, MK;
- Kuzushita, N;
- Mauss, S;
- Núñez, M;
- Nüesch, R
Background:Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available to treat hepatitis B. The most potent an
